<DOC>
	<DOCNO>NCT00847613</DOCNO>
	<brief_summary>This study design provide safety efficacy data support development CP-690,550 patient moderate severe rheumatoid arthritis background methotrexate .</brief_summary>
	<brief_title>A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Adults moderate severe rheumatoid arthritis stable dose methotrexate Pregnancy , severe acute chronic medical condition , include serious infection clinically significant laboratory abnormality .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>double-blind placebo-controlled investigational drug oral therapy safety efficacy hand foot x-ray</keyword>
</DOC>